Diabetes (type 1 and type 2) in children and young people: diagnosis and management

Resource impact statement (diabetes type 1 and type 2 in children and young people and fluid therapy)

No significant resource impact is anticipated

The NICE guideline on diabetes (type 1 and type 2) in children and young people: diagnosis and management was updated in December 2020.

We do not expect this update to have a significant impact on resources; that is:

• the resource impact of implementing any single guideline recommendation in England will be less than £1 million per year (or £1,800 per 100,000 population) and
• the resource impact of implementing the whole guideline in England will be less than £5 million per year (or £9,000 per 100,000 population).

This is because the new recommendations, related to fluid therapy, are in line with current practice and with other existing clinical guidance (such as the International Society for Paediatric and Adolescent Diabetes DKA guideline).

Diabetes services are commissioned by clinical commissioning groups, integrated care systems and strategic transformation partnerships. Providers are NHS hospital trusts, community providers and primary care providers.